Browse hierarchy: [Ophthalmic (OP)](/submissions/OP) → [Subpart F — Therapeutic Devices](/submissions/OP/subpart-f%E2%80%94therapeutic-devices) → [21 CFR 886.5300](/submissions/OP/subpart-f%E2%80%94therapeutic-devices/886.5300) → PQJ — Intranasal Electrostimulation Device

# PQJ · Intranasal Electrostimulation Device

_Ophthalmic · 21 CFR 886.5300 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/OP/subpart-f%E2%80%94therapeutic-devices/PQJ

## Overview

- **Product Code:** PQJ
- **Device Name:** Intranasal Electrostimulation Device
- **Regulation:** [21 CFR 886.5300](/submissions/OP/subpart-f%E2%80%94therapeutic-devices/886.5300)
- **Device Class:** 2
- **Review Panel:** [Ophthalmic](/submissions/OP)

## Identification

A tear electrostimulation device is a non-implantable, electrostimulation device intended to increase tear production.

## Classification Rationale

Class II (special controls). The special controls for this device are:

## Special Controls

In combination with the general controls of the FD&C Act, the Tear Electrostimulation Device is subject to the following special controls:

*Classification.* Class II (special controls). The special controls for this device are:(1) Non-clinical performance testing must assess the following electrical output specifications: waveforms, output modes, maximum output voltage, maximum output current, pulse duration, frequency, net charge per pulse, maximum phase charge at 500 ohms, maximum current density, maximum average current, and maximum average power density.
(2) Patient-contacting components of the device must be demonstrated to be biocompatible.
(3) Performance testing must demonstrate the electrical, thermal, and mechanical safety along with electromagnetic compatibility (EMC) of the device in the intended use environment.
(4) Software verification, validation, and hazard analysis must be performed.
(5) Physician and patient labeling must include:
(i) Summaries of electrical stimulation parameters;
(ii) Instructions on how to correctly use and maintain the device;
(iii) Instructions and explanations of all user-interface components;
(iv) Information related to electromagnetic compatibility classification; and
(v) Instructions on how to clean the device.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN160030](https://fda.innolitics.com/submissions/OP/subpart-f%E2%80%94therapeutic-devices/PQJ/DEN160030.md) | Oculeve Intranasal Tear Neurostimulator Device | Oculeve, Inc. | Apr 24, 2017 | DENG |

## Top Applicants

- Oculeve, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/OP/subpart-f%E2%80%94therapeutic-devices/PQJ](https://fda.innolitics.com/submissions/OP/subpart-f%E2%80%94therapeutic-devices/PQJ)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com